Philip Cole
Impact in
- Oncology top 0.5%
- Cancer Risks and Factors
- Global Cancer Incidence and Screening
- Chemical Health and Safety top 0.5%
Papers in
-
- Carcinogens and Genotoxicity Assessment 21
- Breast Cancer Treatment Studies 10
- Co-authors
- Brian MacMahonJames B. BrownJack S. MandelDimitrios TrichopoulosHans‐Olov AdamiAlan S. MorrisonBrad RoduJohn A. Pinkston
- Journals
- New England Journal of Medicine (12 papers)Cancer (12 papers)International Journal of Cancer (9 papers)American Journal of Epidemiology (9 papers)Regulatory Toxicology and Pharmacology (8 papers)
- Partner nations
- United StatesCanadaSweden
In The Last Decade
Philip Cole
160 papers receiving 10.8k citations
Hit Papers
Peers
Comparison fields: 5 of 193
- Oncology 3.7k
- Chemical Health and Safety 85
- Cancer Research 1.8k
- Health, Toxicology and Mutagenesis 1.5k
- Pathology and Forensic Medicine 1.5k
Countries citing papers authored by Philip Cole
This map shows the geographic impact of Philip Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Cole more than expected).
Fields of papers citing papers by Philip Cole
This network shows the impact of papers produced by Philip Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Cole. The network helps show where Philip Cole may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip Cole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2014 | 144 | |
| 3 | Epidemiology and etiology of Parkinson’s disease: a review of the evidence Hit paper breakdown → | 2011 | 876 |
| 4 | 2008 | 2 | |
| 5 | 2007 | 210 | |
| 6 | 2005 | 45 | |
| 7 | 2004 | 39 | |
| 8 | 1996 | 110 | |
| 9 | 1996 | 56 | |
| 10 | 1994 | 49 | |
| 11 | 1993 | 42 | |
| 12 | 1992 | 97 | |
| 13 | 1992 | 26 | |
| 14 | 1992 | 5 | |
| 15 | 1990 | 98 | |
| 16 | 1990 | 9 | |
| 17 | 1989 | 24 | |
| 18 | 1988 | 113 | |
| 19 | Correspondence re: Harland Austin et al. A Case-Control Study of Hepatocellular Carcinoma and the Hepatitis B Virus, Cigarette Smoking, and Alcohol Consumption. Cancer Res., 46: 962–966, 1986— Reply | 1987 | 1 |
| 20 | 1974 | 98 |
About Philip Cole
Philip Cole is a scholar working on Chemical Health and Safety, Cancer Research, Oncology, Health, Toxicology and Mutagenesis and Otorhinolaryngology, having authored 160 papers that have together received 11.8k indexed citations. Recurring topics across this work include Cancer Risks and Factors (29 papers), Carcinogens and Genotoxicity Assessment (21 papers), Occupational and environmental lung diseases (20 papers), Air Quality and Health Impacts (18 papers), Estrogen and related hormone effects (14 papers), Smoking Behavior and Cessation (13 papers), Global Cancer Incidence and Screening (12 papers) and Breast Cancer Treatment Studies (10 papers). The work is most often cited by research in Oncology (3.7k citations), Chemical Health and Safety (85 citations), Cancer Research (1.8k citations), Health, Toxicology and Mutagenesis (1.5k citations) and Pathology and Forensic Medicine (1.5k citations). Philip Cole has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Brian MacMahon, James B. Brown, Jack S. Mandel, Dimitrios Trichopoulos, Hans‐Olov Adami, Alan S. Morrison, Brad Rodu, John A. Pinkston, Nancy Gutensohn and Robert N. Hoover. Their work appears in journals such as New England Journal of Medicine, Cancer, International Journal of Cancer, American Journal of Epidemiology and Regulatory Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.